Correction to: Safety and efficacy of lamivudine or telbivudine started in early pregnancy for mothers with active chronic hepatitis B

Tianyu He; Yuqing Bai; Haodong Cai; Xiaojuan Ou; Min Liu; Wei Yi; Jidong Jia

doi:10.1007/s12072-018-9876-8

Correction to: Safety and efficacy of lamivudine or telbivudine started in early pregnancy for mothers with active chronic hepatitis B

Hepatol Int. 2018 May;12(3):289. doi: 10.1007/s12072-018-9876-8. Epub 2018 Jun 11.

Authors

Tianyu He¹, Yuqing Bai², Haodong Cai³, Xiaojuan Ou¹, Min Liu², Wei Yi⁴, Jidong Jia⁵

Affiliations

¹ Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, National Clinical Research Center of Digestive Diseases, Liver Research Center, Beijing Friendship Hospital, Capital Medical University, No. 95 Yong-an Road, Xicheng District, Beijing, 100050, China.
² Department of Obstetrics and Gynecology, Beijing Ditan Hospital, Capital Medical University, No. 8 Jing-shun East Street, Chaoyang District, Beijing, 100015, China.
³ Department of Hepatology, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
⁴ Department of Obstetrics and Gynecology, Beijing Ditan Hospital, Capital Medical University, No. 8 Jing-shun East Street, Chaoyang District, Beijing, 100015, China. yiwei1215@163.com.
⁵ Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, National Clinical Research Center of Digestive Diseases, Liver Research Center, Beijing Friendship Hospital, Capital Medical University, No. 95 Yong-an Road, Xicheng District, Beijing, 100050, China. jia_JD@ccmu.edu.cn.

PMID: 29900487
DOI: 10.1007/s12072-018-9876-8

Abstract

The aim of this erratum is to clearly state the individual author's contribution which was erroneously mentioned as "Tianyu He, Yuqing Bai, Wei Yi, and Jidong Jia contributed equally to this work."

Publication types

Published Erratum